Key result
Non-coding RNAs influence cardiac fibrosis progression by regulating TGF-β/Smad signaling pathways.
Why the study?
Comprehensive knowledge of how non-coding RNAs affect TGF-β/Smad signaling in cardiac fibrosis may yield new diagnostic and therapeutic approaches for cardiac disorders.
Understanding the regulation of TGF-β/Smad signaling by non-coding RNAs in cardiac fibrosis may lead to novel diagnostic and therapeutic approaches for various cardiac disorders.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for non-coding RNA-targeted therapies in cardiac fibrosis; leaves open clinical translation pending prospective studies.
Unintended cardiac fibroblast proliferation in many pathophysiological heart conditions, known as cardiac fibrosis, results in pooling of extracellular matrix (ECM) proteins in the heart muscle. Transforming growth factor β (TGF-β) as a pivotal cytokine/growth factor stimulates fibroblasts and hastens ECM production in injured tissues. The TGF-β receptor is a heterodimeric receptor complex on the plasma membrane, made up from TGF-β type I, as well as type II receptors, giving rise to Smad2 and Smad3 transcription factors phosphorylation upon canonical signaling. Phosphorylated Smad2, Smad3, and cytoplasmic Smad4 intercommunicate to transfer the signal to the nucleus, culminating in provoked gene transcription. Additionally, TGF-β receptor complex activation starts up non-canonical signaling that lead to the mitogen-stimulated protein kinase cascade activation, inducing p38, JNK1/2 (c-Jun NH2-terminal kinase 1/2), and ERK1/2 (extracellular signal-regulated kinase 1/2) signaling. TGF-β not only activates fibroblasts and stimulates them to differentiate into myofibroblasts, which produce ECM proteins, but also promotes fibroblast proliferation. Non-coding RNAs (ncRNAs) are important regulators of numerous pathways along with cellular procedures. MicroRNAs and circular long ncRNAs, combined with long ncRNAs, are capable of affecting TGF-β/Smad signaling, leading to cardiac fibrosis. More comprehensive knowledge based on these processes may bring about new diagnostic and therapeutic approaches for different cardiac disorders.
No takes yet. Share an insight, caveat, or question.
Saadat et al. (2021) conducted a review in Cardiac fibrosis. Non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, regulate TGF-β/Smad signaling pathways to influence the development and progression of cardiac fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: